SSSophie Strobl

Sophie Strobl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophie Strobl has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Cross-sectional Study on Quality of Life in EB: Validation of the Italian QOLEB and Assessment in Italian Patients

    by Giovanna Zambruno, Tonia Samela, Andrea Diociaiuti, Gudrun Salamon, Sophie Strobl, Cinzia Pilo, Damiano Abeni, Renata Linertová, Dedee F. Murrell, May El Hachem

    Inherited epidermolysis bullosa comprises a heterogeneous group of skin fragility diseases, presenting with a range of manifestations and complications that profoundly affect quality of life (QoL). A disease-specific instrument, Quality of Life in EB (QOLEB), has been developed to assess the impact of epidermolysis bullosa signs and symptoms on QoL. The aim of this cross sectional study, conducted as part of a European project – BUR-EB, was to test the psychometric properties of the Italian version of the QOLEB and to assess QoL in Italian epidermolysis bullosa patients. Demographic, clinical, and QOLEB data of 56 Italian patients aged ≥11 years participating in the BUR-EB online survey were analysed. Principal component analysis showed excellent internal consistency of Italian QOLEB, and high convergent validity with the generic questionnaire EQ-5D. About 40% of patients reported severe to very severe disease burden, and a strong correlation was observed between disease severity and QOLEB scores. Independent variables associated with worse QoL were pain, chronic wounds, wheelchair use and patient organization membership. Our study confirms the good psychometric properties of the Italian QOLEB. In addition to depicting the major impact of epidermolysis bullosa on QoL, it identifies pain, chronic wounds and functional disability as major targets for therapeutic interventions.

  • Open Access

    Barriers, Benefits and Complications of Orthodontic Treatment in Patients with Epidermolysis Bullosa: A Patient-Reported Cross-Sectional Study

    by Sebastián Véliz, Gudrun Salamon, Milica Kabic, Sophie Strobl, Pedro Diz-Dios, Colomba Besa-Witto, Susanne Krämer

    Introduction: Epidermolysis Bullosa (EB) is a rare genetic condition with skin and mucosal fragility. Patients with EB present extra- and intraoral manifestations that can limit their access to dental treatment, including orthodontic treatment. This research aims to determine the barriers, benefits and complications of orthodontic treatment reported by a group of patients living with EB. Materials and Methods: This observational study included n = 101 patients with a genetic diagnosis of EB. After their regular dental consultation, they were interviewed about factors they considered barriers to accessing orthodontic treatment. Those who underwent orthodontic treatment (n = 24) reflected about their perceived benefits and complications from the therapy. Data were analysed with descriptive statistics and multiple Fisher’s exact tests with false discovery rate (FDR) correction. Results: The most prevalent barrier was that most patients with EB had never been evaluated by an orthodontist (74.3%), even if the teams had an orthodontist. Other barriers included distance to the treatment centre (42.6%), poor oral hygiene (27.7%) and poor oral health status (26.7%). Patients with limited mouth opening perceived greater treatment benefit compared to those without this limitation (φ = −0.28, p = 0.0242), while an increasing age was associated with a reduced perception of treatment benefit (Cramér’s V = 0.29, p = 0.0404). Among those who underwent orthodontic treatment, the most prevalent benefits of orthodontic treatment were aesthetic improvement (62.5%), oral hygiene improvement (20.8%) and occlusal stability (12.5%), while the most prevalent complications were wounds and ulcers (75.0%), gingivitis (54.1%), poor oral hygiene (41.6%) and caries (33.3%). Discussion: People living with EB reported different barriers to orthodontic treatment relating to psychosocial and professional aspects, which vary according to the EB type and severity. The involvement of orthodontists in multidisciplinary special care teams and the reduction in access barriers to dental specialities can be facilitated by a more comprehensive understanding of conditions such as EB.

  • Meta-Analysis of Pain Management in Epidermolysis Bullosa

    by Christian Puttinger, Gretha Hecke, Sophie Strobl, Petra Hitthaler-Waigner, Tobias Welponer, Georg Zimmermann, Martin Laimer, Gudrun Salamon

    Pain is one of the most burdensome symptoms for patients with Epidermolysis bullosa (EB), and due to the disease heterogeneity, pain management requires an individualized approach. This meta-analysis identified nine studies of those four topical and one systemic study showed a significant improvement in pain scores. The variety of different tools used for measuring pain underscore the importance to foster harmonisation in patient reported outcomes measurement tools, especially in pain.


  • Open Access

    Psychometric Properties and Factor Structure of the Revised Epidermolysis Bullosa Burden of Disease (EB-BoD-R) Family Score

    by Gudrun Salamon, Sophie Strobl, Hélène Dufresne, Christine Bodemer, Anja Diem

    Epidermolysis bullosa (EB) is a rare genetic disease defined by high fragility of the skin. The impact of this chronic disease extends beyond the physical and affects the psychosocial well-being and quality of life of not only the affected individuals but also their families. The Epidermolysis Bullosa Burden of Disease (EB-BoD) questionnaire aims to assess the impact of the disease on the family of those affected. Whereas the questionnaire has been partially validated in French, there is no validated English translation. Additionally, the original version is limited to assessing the quality of life of parents only. The objective of this study was to revise the EB-BoD to ensure its applicability to all relatives of individuals with EB, and to translate, culturally adapt and validate it in English. The EB-BoD revised was developed in three stages: (1) translation and cross-cultural adaptation, (2) content revision and thematic adjustment and (3) sample-based testing with 64 relatives of patients with all EB types to establish the psychometric properties of the English EB-BoD-R. The revised EB-BoD exhibits excellent reliability and internal consistency, with a Cronbach’s α of 0.93. Exploratory factor analysis resulted in two distinct factors, Circumstances and Emotions . Convergent validity was demonstrated by strong correlations with the iscorEB-p and the SWLS (both p < .001). Divergent validity was found in relation to social support F-SozU (ρ=−0.17, p = .228). In conclusion, the English EB-BoD-R is an effective and reliable instrument for assessing the quality of life of relatives of EB patients.

  • Open Access

    The psychosocial impact of a chronic disease in Ireland: Burdens and helpful practices for a life with epidermolysis bullosa

    by Gudrun Salamon, Ursula Field‐Werners, Sophie Strobl, Vinzenz Hübl, Anja Diem

    Objective: Although Ireland has one of the highest levels of well‐being in Europe, having a health condition has been found to have a direct negative impact. The aim of this study is to evaluate the current situation and the experiences of patients with epidermolysis bullosa (EB), a rare genetic skin disease, and their relatives living in Ireland, with a focus on burdens and helpful practices.Methods and Measures: In a mixed‐methods design, a series of standardised questionnaires were combined with open‐ended questions. Via an online survey, data from n = 59 EB patients and relatives of EB patients living in Ireland were collected.Results: EB affects both the patients and their relatives. Burdens were found in relation to the visibility of EB, the degree of severity, the current health status, reduced mobility, the financial impact of EB, the psychosocial impact and personal and social resources. The paper also analyses existing resources and highlights opportunities for support and needs of improvement.Conclusion: Quality of life with EB is influenced by somatic symptoms and the psychosocial burden. Individual helpful practices in dealing with this rare disease can be considered as mediators, but they need to be supported by structural and healthcare improvements.Patient or Public Contribution: The perspective of EB patients, their relatives and EB experts were taken into account in the development of the study design via two feedback loops with the EB patient organisations DEBRA Ireland and DEBRA Austria. The design was adapted accordingly. Additionally, by including open‐ended questions, patients and relatives could contribute their individual perspectives and add insights into their lives with EB that might not have been captured with the structured online survey alone.


  • Open Access

    Facing the complex challenges of people with epidermolysis bullosa in Austria: a mixed methods study on burdens and helpful practices

    by Gudrun Salamon, Ursula Field-Werners, Sophie Strobl, Vinzenz Hübl, Anja Diem

    Background: With approximately 500 people affected in Austria, epidermolysis bullosa (EB) is a rare genetic skin disease reducing the quality of life of those affected and their relatives. The intensive efforts of the patient organisation DEBRA Austria during the last decades have led to a unique situation of those affected and their relatives, with increased support and broader knowledge about the disease in the general population. The aim of the study is to evaluate the current situation of patients and their relatives living in Austria, with a focus on burdens and helpful practices. Results: The mixed-methods study consisted of two parts: a qualitative interview study to identify psychosocial aspects of EB in those affected and their relatives, and a subsequent online survey to further assess those aspects in a larger sample, resulting in a total of n=78 Austrian participants. The impact of EB on the quality of life of EB patients and their relatives in Austria is related to the current health status, psychological burden, mobility, visibility, financial situation as well as job prospects. Personal and social resources and external support have a significant influence on the individual situation. Conclusions: The outcome is mapped to concrete implications regarding targeted support for EB patients and their relatives on an individual level and their needs in regard to the Austrian health care system.


  • Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure

    by Gudrun Salamon, Sophie Strobl, Ursula Field-Werners, Anja Diem, Agnes Schwieger-Briel, Elena Pope

    In contrast to clinical diagnosis via external examination, patient-related outcome measures allow to access the patients’ internal perception. Particularly, in the case of epidermolysis bullosa (EB), a rare disease characterized by a wide variety of symptoms and individual courses of disease, it is central to integrate the patient’s perspective into diagnostic processes. The Instrument for Scoring Clinical Outcome of Research for EB (iscorEB) is an EB-specific measurement tool, combining a clinician score (iscorEB-c) and a patient questionnaire (iscorEB-p). The aim of this study is to establish the iscorEB-p as an independent patient-related outcome measure tool by exploring its psychometric properties. The following steps were performed on data collected via a multinational online cross-sectional study: sample-based psychometric testing and evaluation. Data analysis was performed with n=95 participants across all EB types. The reliability and internal consistency of the iscorEB-p was excellent (α=0.90). A principal component analysis with a varimax rotation resulted in a two-factor solution, explaining 55.6% of the total variance, with the distinct factors “everyday life functioning” and “specific EB symptoms”. Convergent validity was shown by high correlations to the SWLS (r=-0.52, pp<0.001) and EB-BoD (r=-0.73, p<0.001). In conclusion, the iscorEB-p is a reliable and valid instrument to assess the patient-reported view on the health status of EB patients.